For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Sony Biotechnology: Sonoma Biotherapeutics’ Cell Sorter Experience in Isolation of T Reg-Cells – Incorporating the CGX10 Cell Isolation System
Wednesday, May 29, 2024 12:00 PM - 01:00 PM  
Room 211
Corporate Session

Speakers
  • Erin Massey, Scientist II, Process Development, Sonoma Biotherapeutics, USA
  • Aditi Singh, PhD, Global Senior Product Manager, Sony Biotechnology Inc., USA
Chair
  • Alexey Bersenev, MD, PhD, Assistant Professor of Laboratory Medicine, Yale University, United States 
Sonoma Biotherapeutics currently has a cell therapy product in phase I clinical trials, an autologous T regulatory cell therapy with an indication focused on patients suffering from Rheumatoid Arthritis. Sonoma currently uses cell sorting in its manufacturing process to sort T regulatory cells. Sony Biotechnology offers one of the few cell sorters on the market with throughput high enough for Sonoma Biotherapeutics’s process that can be used in GMP manufacturing. Sonoma has been investigating the CGX10 cell isolation system as a potential alternative for several reasons - ease of use, it being a fully closed system and for 21 CFR Part 11 compliance. Following the discussion on how Sonoma Biotherapeutics in using the new system, Sony Biotechnology team will share CGX10 system overview and application data.

Session Objective
• Sonoma Biotherapeutics cell sorter experience in isolation of T regulatory cells.
• How the Sony CGX10 Cell Isolation system- a fully GMP ready system, enables multiparametric isolation of rare cell populations
SPONSORED BY:
Erin Massey
Scientist II
 Sonoma Biotherapeutics
 Speaker
Aditi Singh; Ph.D
Global Senior Product Manager
 Sony Biotechnology Inc.
 Speaker
Alexey Bersenev
Assistant Professor, Laboratory Director
 Yale University
 Chair